UNSPSC 85811821: Introduction of monoclonal antibody into cranial cavity and brain, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into cranial cavity and brain, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0Q30M

UNSPSC 85811821, Introduction of monoclonal antibody into cranial cavity and brain, percutaneous approach, is a Commodity code that does not reflect the scope of recent state and local procurement activity tagged under it. The recent opportunities block shows no solicitations for neurosurgical or oncological procedures involving monoclonal antibody administration; instead, the code's recent state and local contracts span virtual urgent care services, general medical services, nursing home operations, occupational health screening, cancer registry services, behavioral health programs, and opioid use disorder treatment and recovery initiatives across California, Georgia, Nevada, Colorado, Florida, and other jurisdictions. The mismatch between the code's clinical description and actual buying activity suggests a taxonomy tagging error or a data quality issue in the source material.

The opportunities that do appear under this code—which range from Inland Empire Health Plan's RFI for 24/7 virtual urgent care (due October 31, 2026) to the Nevada Health Authority's PACE and Rural Value Acceleration Network RFPs (proposals due December 10, 2026 and November 30, 2026 respectively), San Mateo County's cancer registry and retinal screening device RFPs, and widespread opioid settlement-funded treatment and recovery programs across Kansas, Colorado, and other states—target health systems, behavioral health departments, public hospitals, and county health authorities rather than surgical or neurology-specific providers. No bidding entities pursue this code for monoclonal antibody infusion services, neurological procedure-level work, or the oncology and immunotherapy sector implied by the Commodity name. State and local procurement under this code identifier appears dormant or systematically miscoded; business development professionals should verify correct UNSPSC classification before pursuing opportunities posted under this number or flag the discrepancy to the issuing body's procurement office.